Stock GTHX G1 THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart G1 Therapeutics, Inc.

Equities

GTHX

US3621LQ1099

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-16 pm EDT 		5-day change 1st Jan Change
4.68 USD -0.21% Intraday chart for G1 Therapeutics, Inc. -6.02% +53.44%
May. 01 Transcript : G1 Therapeutics, Inc., Q1 2024 Earnings Call, May 01, 2024
May. 01 Earnings Flash (GTHX) G1 THERAPEUTICS Reports Q1 Revenue $14.5M, vs. Street Est of $15.1M MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
G1 THERAPEUTICS, INC. Stock G1 Therapeutics, Inc.
 245M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 114B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
ARGENX SE Stock argenx SE
 22.28B -
BIONTECH SE Stock BioNTech SE
 22.41B -
GENMAB A/S Stock Genmab A/S
 19.07B
  1. Stock Market
  2. Equities
  3. GTHX Stock
  4. Charts G1 Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW